Global Spinal Fusion Device Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
Spinal fusion devices market size is projected to reach US$ 9.99 Billion by 2030, according to Renub Research. Spinal Fusion surgery is used to rectify disorders related to small bones in the spine. The procedure involves the fusion of two or more vertebrae in the vertebral column to treat degenerative discs, fractured vertebrae, spondylolisthesis, disc herniation, and spinal canal stenosis, among others. In recent years, the number of spine fusion surgeries has gradually increased. This is due to the rising prevalence of spine-associated deformities caused primarily by aging, road traffic crashes, falls, or violence.
 Spinal fusion devices treat spinal deformities such as degenerative disc disease and spondylolisthesis. The market's growth is driven by an increase in the geriatric population and a rise in incidences of spinal disorders. expansion in indications for which spinal fusion surgery is performed boosts the market growth. For instance, spinal fusion was initially performed solely for scoliosis and spinal tuberculosis. However, there are 14 conditions for which spinal fusion procedure is currently indicated. In addition, in 2020, 153,288 anterior cervical discectomy and fusions were performed in the U.S., and the volume is expected to increase by 13.3% by 2040.
Global spinal fusion devices market is projected to grow at a CAGR of 3.98% from 2024 to 2030
The global population is aging rapidly due to reduced birth rates and increasing life expectancy. The demographic trend towards an aging population represents an increasing need to manage old age-associated spine disorders. In 2021, according to the World Health Organization, 1 out of every 6 people will be 60 years old or older by 2030. The number of people aged 60 and above is anticipated to increase upward from 1 Billion in 2020 to 1.4 Billion by 2050. By 2050, the worldwide population of elderly people 60 and above will double to reach 2.1 billion. Between 2020 and 2050, the number of human beings aged 80 and above is predicted to triple, attaining 426 million. These physiological modifications and prolonged exposure to risk factors increase the prevalence rate of backbone disorders, which may also require surgical intervention.
In May 2022, according to the ""Spinal Cord Injuries"" report, 250,000 and 500,000 people worldwide suffer from spinal cord injury yearly. Most instances result from preventable factors including violence and vehicles injuries. Approximately 17,000 new spinal cord injury instances are reported yearly within the United States, with a predicted 282,000 peoples dwelling with SCI. The majority of patients with SCI caused by a sports injury are men. The age group from 16 to 30 years has the highest threat of SCI. Thus, the high incidence of spinal cord injuries will surge the demand for spinal fusion devices over the approaching years. Furthermore, the increasing preference for minimally invasive surgical procedures because of numerous benefits propels the market growth.
Single-position anterior lumbar fusion surgical treatment allows surgeons to complete the whole operation while the patients is at their side. Technological advancements in surgical techniques are also a key factor driving the market's growth. In November 2022, Sentinel Spine LLC announced the recent publication of a peer-reviewed look at of the STALIF M portfolio of products in a worldwide journal in November of Spine Surgery: ""Evaluation of Anterior Lumbar Interbody Fusion Using a Stand-Alone, Integrated Fusion Cage."" The STALIF M implant technology is primarily based at the STALIF technology platform, with over 30 years of confirmed medical records and over 75,000 devices implanted. As a result, Spinal Fusion Devices Market Size is valued at USD 7.60 Billion in 2023.
Cervical segment is expected to grow significantly within the spinal fusion devices market throughout the forecast timeframe
Product Type, the Spinal Fusion Devices Market is segmented into Cervical Devices, Thoracolumbar Devices, Interbody Devices, and Biologics. In spinal fusion devices, the cervical segment is poised for a substantial and quick enlargement in the foreseeable future. Projections suggest that this particular sector will surge in demand and prominence. This upsurge is expected to be pushed via various factors, which includes technological advancements, increasing patient’s awareness, and a growing incidence of cervical spine-related troubles. As a result, companies within the spinal fusion device industry are gearing up to innovate and cater to this burgeoning market. The cervical sector predicted speedy increase highlighting the evolving panorama of medical technology and its commitment to addressing crucial healthcare needs.
Minimally invasive surgical surgery segment held the largest spinal fusion device market revenue proportion
By Surgery Type, the Spinal Fusion Devices Market is split into Minimally Invasive and Open Spine Surgery. Within the spinal fusion device market, the minimally invasive surgical surgery section become the dominant force in terms of sales. This section emerged as the frontrunner, capturing the lion's proportion of the market's financial returns. The popularity of minimally invasive methods has surged notably in recent years due to their numerous advantages. These strategies commonly involve smaller incisions, decreased recovery times, and much less postoperative discomfort, making them an appealing choice for patients and healthcare companies. This trend underscores a growing preference for less invasive surgical techniques within the spinal fusion device landscape, emphasizing the importance of innovation and performance inside the medical field.
Market for spinal fusion devices was controlled by hospitals, representing the largest market share
By End User, the Spinal Fusion Devices Market is classified into Hospitals, Specialty Clinics, and Others. Hospitals, with the most significant marketplace, played a pivotal role in the spinal fusion device market. These healthcare establishments wielded a considerable impact and held a dominant position. This dominance may be attributed to different factors, which include the excessive extent of spinal fusion procedures conducted in clinic settings and their functionality to provide comprehensive spinal care services. Hospitals are appropriately geared up for complex spinal surgical procedures, making them a dependent choice for patients and healthcare specialists. Their strong presence underscored their primary role in the spinal fusion devices market, emphasizing the importance of their know-how and infrastructure in delivering delicate spinal care.
Asia Pacific Spinal fusion device market will increase due to growing older population and road accident
By Countries, Spinal Fusion Devices Market is split into North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey), Asia Pacific (China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand), South America (Brazil, Mexico, Argentina), Middle East & Africa (Saudi Arabia UAE, and South Africa). The Asia Pacific region is poised for a significant spinal fusion device market surge. Projections indicate that this sector will witness rapid growth in the foreseeable future.
This growth is driven by several key factors, including an expanding aging population, increasing instances of spinal conditions, and advancements in medical technology. The demand for spinal fusion devices is expected to rise as healthcare infrastructure improves and awareness of treatment options increases. This burgeoning market reflects the China and India region's evolving healthcare landscape and the commitment to addressing spinal health issues. As the Asia Pacific region continues to invest in healthcare advancements, the rapid growth of the spinal fusion device market signifies a promising future for patients and the industry.
Key Players
Prominent market participants include Medtronic Plc, Stryker Corporation, Zimmer Biomet Holdings, Orthofix Medical Inc., NuVasive Inc., Globus Medical Inc., Xtant Medical Holdings, and Alphatec Holdings Inc.
Renub Research latest report “Global Spinal Fusion Device Market by Product Type (Cervical Devices, Thoracolumbar Devices, Interbody Devices, Biologics), Surgery Type (Minimally Invasive Spine Surgery, Open Spine Surgery), End-Users (Hospitals, Specialty Clinics, Others), Regions (North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey), Asia-Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand), Latin America (Brazil, Mexico, Argentina) and MEA (Saudi Arabia, UAE and South Africa)), Company Analysis (Medtronic Plc, Stryker Corporation, Zimmer Biomet Holdings, Orthofix Medical Inc., NuVasive Inc., Globus Medical Inc., Xtant Medical Holdings, and Alphatec Holdings Inc.)” provides a detailed analysis of Global Spinal Fusion Device Industry.
Product Type – Market Breakup has been covered from 4 viewpoints
1. Cervical Devices
2. Thoracolumbar Devices
3. Interbody Devices
4. Biologics
Surgery Type – Market Breakup has been covered from 2 viewpoints
1. Open Surgery
2. Minimally Invasive
End Users – Market Breakup has been covered from 3 viewpoints
1. Hospitals
2. Specialty Clinics
3. Others
Regions – Market Breakup has been covered from 5 viewpoints
1. North America
1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherland
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
Company Insights:
• Overview
• Recent Development
• Revenue
Company Analysis:
1. Medtronic Plc
2. Stryker Corporation
3. Zimmer Biomet Holdings
4. Orthofix Medical Inc.
5. NuVasive Inc.
6. Globus Medical Inc.
7. Xtant Medical Holdings
8. Alphatec Holdings Inc.